International Journal of Cancer · 1976 · 39 citations · 28 references
Life SciencesImmunologyOncologyCancer ImmunologyCellular ImmunologyTumor ImmunologyAntibody CharacterizationAntibody-antigen RecognitionHuman Leukocyte Antigen SystemTumor AntigensTumor-associated AntigensHuman Leukocyte Antigen AntibodiesHuman Leukocyte AntigensMelanoma-associated AntigensReactivity
Antibody-dependent cell-mediated cytotoxic assays have been used to examine antigens on human melanoma cells obtained either directly from patients or from long-term melanoma cell lines. A panel of melanoma antisera was selected from human subjects which could be shown not to have significant reactivity to histocompatibility antigens. With these antisera extensive cross-reactions between melanoma cells were found. However, the cross-reactivity was incomplete and the pattern of reactivity was different for each antiserum tested. These results were not consistent with a common melanoma antigen on human melanoma cells but rather indicated heterogeneity of melanoma antigens and multiple antibody specificities in the sera tested. This appeared to be confirmed by extensive cross-absorption studies which indicated limited cross-reactivity of antigens on melanoma cells from either long-term or short-term cultures. Several changes in the antigenic profile of melanoma cells in vitro from both long-term and short-term cultures were documented which resulted from contamination of the melanoma cell lines with non-melanoma cells and fibroblasts. Melanoma antisera may therefore be useful to mintor changes in long-term cultures which would otherwise give spurious results in in vitro tests. These results appear to have considerable significance for understanding tumour/host relationships and for the establishment of rational immunotherapeutic procedures and diagnostic tests in melanoma.
28
Martin Lewis, R. L. Ikonopisov, R. C. Nairn et al. · BMJ · 1969 · 394 citations · Full text
Life Sciences, Immunology, Oncology +14
Demonstration of antibodies against human malignant melanoma by immunofluorescence.
Morton Dl, Malmgren Ra, Holmes Ec et al. · PubMed · 1968 · 388 citations
Life Sciences, Immunology, Oncology +12
Transplantation methods as a tool for detection of tumor-specific antigens.
Sjögren Ho · PubMed · 1965 · 222 citations
Life Sciences, Immunology, Oncology +14